Researchers today said that for the first time they have clinical evidence that a series of lifestyle changes and medical interventions can slow cognitive decline from Alzheimer’s or other neurodegenerative diseases.
The authors of the study, which was published today in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, said it was the first “in a real world clinic setting” to show that precision or personalized medical management may improve cognitive function, and reduce Alzheimer’s or cardiovascular risk across a broad range of individuals.
“Instead of giving a ‘one-size-fits-all’ plan, doctors can now use precision medicine to tailor a specific set of suggestions for each individual,” neurologist and study author Richard Isaacson said in an interview with Being Patient.
